Concepedia

Frank Gebhardt

FG

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

1998

Affiliations

Silence Therapeutics (Germany)(Current)

University of Münster

Universitätsklinik Marien Hospital Herne

Klinikum Arnsberg

Imperial College London

Frank Gebhardt is an author at Silence Therapeutics (Germany) specializing in molecular oncology, oncology, and medicine.

Publications per year

1998–2020

9

Publications

9

Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1

Frank Gebhardt, Kurt S. Zänker, Burkhard Brandt · Journal of Biological Chemistry · 1999 · 381 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin

Graeme M. Birdsey, Nicola H. Dryden, Valérie Amsellem et al. · Blood · 2008 · 272 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Beate Schultheis, Dirk Strumberg, Ansgar Santel et al. · Journal of Clinical Oncology · 2014 · 257 citations

Medicine, Pharmacology, Pharmacotherapy +17

Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.

Horst Buerger, Frank Gebhardt, Hartmut Schmidt et al. · PubMed · 2000 · 150 citations

Medicine, Genetics, Oncology +17

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study

Beate Schultheis, Dirk Strumberg, Jan Kuhlmann et al. · Cancers · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 9